NCT00140400
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
Not specified
Clinical trial condition
Neoplasm Metastasis
Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.
2,449 public trials
497 recruiting studies
Neoplasm Metastasis trial results
Completed
Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases
NCT00119899
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Liver Metastases, +14 more
- Locations
-
- UMC ST Radboud Nijmegen, Gelderland, Netherlands
- MMC Veldhoven, North Brabant, Netherlands
- UMCVU Amsterdam, North Holland, Netherlands
- UMCG Groningen, Provincie Groningen, Netherlands
NCT00055562
- Conditions
- Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Southern California Norris Cancer Center Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- St. Francis Memorial Hospital San Francisco, California, United States
NCT00041808
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
- Locations
-
- Scripps Stevens Cancer Division San Diego, California, United States
- UCSF Cancer Center San Francisco, California, United States
- Scott and White Clinic Temple, Texas, United States
- Frankfurt Universtiy Frankfurt, Germany
Completed
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
NCT00051779
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Highlands Oncology Group Springdale, Arkansas, United States
- Bay Area Cancer Research Group Concord, California, United States
- California Cancer Care, Inc. Greenbrae, California, United States
NCT05572684
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
- Locations
-
- Arizona Oncology Associates Tucson, Arizona, United States
- Rocky Mountain Cancer Centers Aurora, Colorado, United States
- St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
- Ochsner Cancer Institute New Orleans, Louisiana, United States
NCT05065736
- Conditions
- Adenocarcinoma, Carcinoma, Metastatic Cancer, +7 more
- Locations
-
- Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Terminated
High Dose IL-2 in Combination With Anti-PD-1
NCT03991130
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
Suspended
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
NCT04840589
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Mount Sinai Hospital New York, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States